STRS Ohio’s Matinas BioPharma MTNB Stock Holding History

STRS Ohio’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-308	Closed	-$20K	–	1915
2017 Q3	$20K	Hold	308	–	–	﹤0.01%	1866
2017 Q2	$26K	Buy	+308	New	+$41.4K	﹤0.01%	1868

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWMG

Alliance Wealth Management Group Flemington, New Jersey $457M AUM 12.13% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

STRS Ohio's MTNB Position: Q4 2017 in Review

STRS Ohio sold out of Matinas BioPharma (MTNB) in Q4 2017, closing a stake of 308 shares — an estimated $20K sold.

STRS Ohio first reported a position in MTNB in Q2 2017 and held it in 2 quarters. The position peaked at $26K in Q2 2017. 49 funds tracked by Wall St. Rank hold MTNB as of Q4 2017.

STRS Ohio reported no remaining Matinas BioPharma position as of Q4 2017 after selling out during the quarter.
STRS Ohio sold 308 Matinas BioPharma shares in Q4 2017, an estimated $20K.
STRS Ohio first reported a position in Matinas BioPharma in Q2 2017 and held it in 2 quarters.
STRS Ohio's Matinas BioPharma position peaked at $26K in Q2 2017.
49 funds tracked by Wall St. Rank held Matinas BioPharma as of Q4 2017.

Based on STRS Ohio's 13F filing for Q4 2017, filed 23 Jan 2018.